Altrenogest
CAS No. 850-52-2
Altrenogest ( Altrenogest | A 35957 | A-35957 | Allyl trenbolone | DRC 6246 | R 2267 | REGU-MATE )
产品货号. M16177 CAS No. 850-52-2
Altrenogest (Allyltrenbolone) 是孕激素,结构与trenbolone相关,能作用于孕激素受体。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 50MG | ¥365 | 有现货 |
|
| 100MG | ¥518 | 有现货 |
|
| 200MG | ¥948 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Altrenogest
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Altrenogest (Allyltrenbolone) 是孕激素,结构与trenbolone相关,能作用于孕激素受体。
-
产品描述Altrenogest(A35957; RU2267) is a progestogen structurally related to veterinary steroid trenbolone.(In Vitro):Altrenogest (Allyltrenbolone) is a progestogen structurally related to veterinary steroid trenbolone. Treatment of embryo-recipient mares with Altrenogest (Allyltrenbolone) appears to be beneficial in extending the degree of donor-recipient synchrony required for successful embryo transfer. The oil and gel Altrenogest (Allyltrenbolone) preparations are equally effective in modulating estrous behavior and time to estrus and ovulation. Altrenogest (Allyltrenbolone) treatment started late in diestrus appears to result in a high incidence of ovulation during treatment and when luteolysis and ovulation occur during treatment; the subsequent luteal phase is frequently prolonged due to failure of regression of the CL.
-
体外实验Altrenogest (Allyltrenbolone) is a progestogen structurally related to veterinary steroid trenbolone. Treatment of embryo-recipient mares with Altrenogest (Allyltrenbolone) appears to be beneficial in extending the degree of donor-recipient synchrony required for successful embryo transfer. The oil and gel Altrenogest (Allyltrenbolone) preparations are equally effective in modulating estrous behavior and time to estrus and ovulation. Altrenogest (Allyltrenbolone) treatment started late in diestrus appears to result in a high incidence of ovulation during treatment and when luteolysis and ovulation occur during treatment; the subsequent luteal phase is frequently prolonged due to failure of regression of the CL.
-
体内实验——
-
同义词Altrenogest | A 35957 | A-35957 | Allyl trenbolone | DRC 6246 | R 2267 | REGU-MATE
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体ER
-
研究领域Endocrinology
-
适应症——
化学信息
-
CAS Number850-52-2
-
分子量310.43
-
分子式C21H26O2
-
纯度>98% (HPLC)
-
溶解度Ethanol: 2 mg/mL (6.44 mM); DMSO: 62 mg/mL (199.72 mM)
-
SMILESC[C@@]12[C@@](CC=C)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CCC4=C3C=C2)=O
-
化学全称(8S,13S,14S,17R)-17-allyl-17-hydroxy-13-methyl-1,2,6,7,8,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Squires EL, et al. J Anim Sci, 1983, 56(4), 901-910.
产品手册
关联产品
-
Estrogen receptor mo...
雌激素受体调节剂 1 可使他莫昔芬耐药、激素非依赖性异种移植肿瘤消退。雌激素受体调节剂 1 是一种口服活性选择性雌激素受体调节剂 (SERM) (pIC50: 0.46)。
-
PROTAC ERRα ligand 2
PROTAC ERRα配体2是一种雌激素相关受体α(ERRα)反向激动剂(IC50:5.67 nM)
-
Mifepristone
米非司酮是一种孕激素和糖皮质激素拮抗剂。
021-51111890
购物车()
sales@molnova.cn

